Clinical Trial Update: Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression [Phase 4]

View source ↗

Summary

Phase 4 trial looking at melancholic depression and insomnia as predictors of response to quetiapine in patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Saskatchewan | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2019-12-04